Cargando…

COVID 19 mimicking HUS in a toddler

Detalles Bibliográficos
Autores principales:	Baliga, R., Jagdish, Apoorva, Pichillinque, Patricia, Warrier, Raj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Production and hosting by Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686313/ http://dx.doi.org/10.1016/j.phoj.2022.10.080

Ejemplares similares

Coronavirus Disease 2019 (COVID-19) Associated Hemolytic Uremic Syndrome in a Toddler
por: Searcy, Kristie, et al.
Publicado: (2022)

Atypical HUS relapse triggered by COVID-19
por: Ville, Simon, et al.
Publicado: (2021)

Atypical HUS Triggered by COVID-19: A Case Report
por: Tiwari, Vaibhav, et al.
Publicado: (2022)

COVID-19 as a potential trigger of complement-mediated atypical HUS
por: El Sissy, Carine, et al.
Publicado: (2021)

Genetics and complement in atypical HUS
por: Kavanagh, David, et al.
Publicado: (2010)

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
por: Fakhouri, Fadi, et al.
Publicado: (2021)

Risk Factors for Short- and Long-Term Outcomes in Children With STEC-HUS/D(+) HUS: A Single-Center Experience
por: VanSickle, Judith Sebestyen, et al.
Publicado: (2018)

Remission of aHUS neurological damage with eculizumab
por: Ávila, Ana, et al.
Publicado: (2015)

Eculizumab and aHUS: Spotlight on Patient-Centered Care
por: Rafat, Cédric, et al.
Publicado: (2020)

Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
por: Kelen, Kata, et al.
Publicado: (2023)

The global aHUS registry: methodology and initial patient characteristics
por: Licht, Christoph, et al.
Publicado: (2015)

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
por: Oh, Jisu, et al.
Publicado: (2019)

HUS1 as a Potential Therapeutic Target in Urothelial Cancer
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2010)

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013)

Ravulizumab for the Treatment of aHUS in Adults: Improving Quality of Life
por: Legendre, Christophe, et al.
Publicado: (2021)

Platelet thrombus formation in eHUS is prevented by anti-MBL2
por: Kushak, R. I., et al.
Publicado: (2019)

OsHUS1 Facilitates Accurate Meiotic Recombination in Rice
por: Che, Lixiao, et al.
Publicado: (2014)

Mikroangiopathien in der Schwangerschaft: HELLP/aHUS/TTP unter Berücksichtigung von COVID-19 in der Schwangerschaft
por: Abou-Dakn, Michael
Publicado: (2022)

Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016)

An Unusual Case Report of a Toddler with Metastatic Neuroblastoma Mimicking Myasthenia Gravis
por: Assaf, Raymen Rammy
Publicado: (2022)

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
por: Pape, Lars, et al.
Publicado: (2016)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
por: Umscheid, Jacob H., et al.
Publicado: (2021)

POS-041 HAEMOLYTIC URAEMIC SYNDROME (HUS) WITH COVID-19 INFECTION: 2 CASE REPORTS. IS THERE A DIRECT LINK?
por: Maharaj, N., et al.
Publicado: (2021)

Håndværkertilbud i Texas Hus med plads til partikelaccelerator
Publicado: (2009)

Atypical hemolytic uremic syndrome (aHUS) responsive to mycophenolate mofetil: A case report from Nepal
por: Gurung, Jyoti, et al.
Publicado: (2022)

Erratum to: aHUS caused by complement dysregulation: new therapies on the horizon
por: Waters, Aoife M., et al.
Publicado: (2012)

Eculizumab Treatment for Postpartum HELLP Syndrome and aHUS—Case Report
por: Lokki, A. Inkeri, et al.
Publicado: (2020)

Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
por: Bouwmeester, Romy N., et al.
Publicado: (2021)

Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?
por: Spasiano, Andrea, et al.
Publicado: (2023)

Pulmonary Renal Syndrome due to Atypical HUS in a Young Gentleman
por: Rajarajan, Arun P., et al.
Publicado: (2023)

Fecal diagnostics in combination with serology: best test to establish STEC-HUS
por: Wijnsma, Kioa L., et al.
Publicado: (2016)

L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)
por: Kanzelmeyer, Nele Kirsten, et al.
Publicado: (2014)

Relevance of Bacteriophage 933W in the Development of Hemolytic Uremic Syndrome (HUS)
por: Del Cogliano, Manuel E., et al.
Publicado: (2018)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
por: Cheung, Chee Kay, et al.
Publicado: (2019)

Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
por: Kelen, Dorottya, et al.
Publicado: (2021)

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)

COVID-19–Associated Immune Thrombocytopenia in a Toddler
por: Vadakkekara, Jayakrishnan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nurvooqb7m6c3a6lsagfbl33uv